These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6594127)

  • 21. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
    Prathibha D; Govardhani M; Krishna PT
    J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperprolactinaemia in males: a heterogeneous disorder.
    Walsh JP; Pullan PT
    Aust N Z J Med; 1997 Aug; 27(4):385-90. PubMed ID: 9448878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation and management of symptomatic hyperprolactinaemia.
    Holdaway IM; Frengley PA; Mountjoy KG; Ibbertson HK; Graham FM; France JT
    Aust N Z J Obstet Gynaecol; 1979 May; 19(2):100-6. PubMed ID: 292425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography.
    Johnston DG; Hall K; Kendall-Taylor P; Ross WM; Crombie AL; Cook DB; Watson MJ
    Clin Endocrinol (Oxf); 1986 Jun; 24(6):675-85. PubMed ID: 3098457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
    Zárate A; Canales ES; Alger M; Forsbach G
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):407-12. PubMed ID: 517046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of new diagnostic methods on the differential diagnosis and treatment of secondary amenorrhoea.
    Shearman RP; Fraser IS
    Lancet; 1977 Jun; 1(8023):1195-7. PubMed ID: 68286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term radiographic follow-up of the sella turcica in hyperprolactinaemic women.
    Rasmussen C; Larsson SG; Bergh T
    Aust N Z J Obstet Gynaecol; 1990 Aug; 30(3):257-64. PubMed ID: 2256866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine in management of large pituitary tumours.
    Wass JA; Williams J; Charlesworth M; Kingsley DP; Halliday AM; Doniach I; Rees LH; McDonald WI; Besser GM
    Br Med J (Clin Res Ed); 1982 Jun; 284(6333):1908-11. PubMed ID: 6805756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine treatment of males with pituitary tumours, hyperprolactinaemia, and hypogonadism.
    Nagulesparen M; Ang V; Jenkins JS
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):73-9. PubMed ID: 679504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The occurrence of macroscopical pituitary calcifications in prolactinomas.
    Rasmussen C; Larsson SG; Bergh T
    Neuroradiology; 1990; 31(6):507-11. PubMed ID: 2352634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute pituitary failure as the presentation of a prolactin cell adenoma during a pregnancy made possible by bromocriptine (author's transl)].
    Linquette M; Buvat J; Gauthier A; Gasnault JP; Pagniez I; Decoulx M; Laine E
    Nouv Presse Med; 1977 Nov; 6(38):3525-L, 3531. PubMed ID: 600724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine.
    Zárate A; Canales ES; Cano C; Pilonieta CJ
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):139-42. PubMed ID: 6356741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of amenorrhoea, galactorrhoea and hypogonadism with bromocriptine.
    Donald RA; Espiner EA; Livesey JH
    Aust N Z J Med; 1978 Jun; 8(3):262-6. PubMed ID: 279321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size.
    van 't Verlaat JW; Croughs RJ
    Clin Endocrinol (Oxf); 1991 Mar; 34(3):175-8. PubMed ID: 2036725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancies in women with hyperprolactinaemia: obstetric and endocrinological management of 50 pregnancies in 37 women.
    Randall S; Laing I; Chapman AJ; Shalet SM; Beardwell CG; Kelly WF; Davies D
    Br J Obstet Gynaecol; 1982 Jan; 89(1):20-3. PubMed ID: 7059541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review.
    Weil C
    Curr Med Res Opin; 1986; 10(3):172-95. PubMed ID: 3525009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperprolactinaemia and female infertility.
    Godó G
    Acta Med Hung; 1984; 41(4):185-93. PubMed ID: 6440115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.